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Background: Very low levels of cardiac troponin (Tn) are associated with increased mortality, even among patients without overt obstructive 
coronary artery disease (CAD). We tested the hypothesis that in pts without overt obstructive CAD, those with detectable Tn will show abnormal 
coronary flow reserve (CFR, reflecting diffuse atherosclerosis and microvascular dysfunction), and that Tn positivity and abnormal CFR will be 
associated with adverse clinical outcomes.
methods: We included 650 consecutive pts with chest pain or dyspnea, but without a history of prior CAD, undergoing myocardial perfusion PET 
imaging showing no evidence of obstructive CAD and normal ejection fraction (≥40%). Myocardial blood flow (MBF, mL/min/g) was quantified at 
rest and at peak stress. CFR was estimated from the ratio of stress/rest MBF. Serum Tn levels were measured within 14 days prior to PET imaging. 
Pts were followed for a median of 1.79 years [0.92-2.66] for the occurrence of major adverse clinical events (MACE) including death, myocardial 
infarction, or late revascularization.
results: Tn positive pts were older (median age: 65 vs. 61 yrs for Tn negative pts, p<0.001). However, Tn positive and negative pts were balanced 
with respect to gender, hypertension, dyslipidemia, and diabetes. Compared with Tn negative pts (n=560), those with positive Tn (n=90) had lower 
peak MBF (1.87 [1.48-2.59] vs 2.27 [1.69-2.89] mL/min/g, p=0.0004) and CFR (1.82 [1.68-1.96] vs. 2.11 [2.06-2.18], p=0.0003). After adjusting 
for age, sex, race, hypertension, hyperlipidemia, diabetes, smoking, body mass index, and LV mass index, there was a significant inverse association 
between Tn and CFR (beta -0.24, [95% CI -0.40 to -0.08], p=0.0029). 55 pts experienced MACE, including 37 deaths. In survival analysis, age (HR 
1.0 [1.01-1.07]), male gender (HR 2.28 [1.25-4.17]), tobacco use (HR 2.77 [1.26-6.06]), positive Tn (HR 2.0 [1.12-3.79]), and higher CFR (HR 
0.43 [0.25-0.73]) were significantly associated with MACE.
conclusions: In pts without overt CAD, a detectable Tn is associated with reduced coronary vascular reactivity. Both Tn positivity and impaired CFR 
are associated with worse clinical outcomes.
